cevimeline hydrochloride
NDC 0054-0893, cevimeline hydrochloride, capsule, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0054-0893
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091591
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0893 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CEVIMELINE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0893-25 | 00054089325 | 100 CAPSULE in 1 BOTTLE (0054-0893-25) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/8da082f8-a6a3-46b3-8405-fbc4c220e60b
Use it
Look up 0054-0893 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0893 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0893. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.